Pharmadrug (TSE:PHRX) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
PharmaDrug Inc. is issuing $414,523 in debenture units to replace outstanding convertible debentures, providing investors an opportunity to convert them into common shares. The issuance includes 8,290,000 common share purchase warrants, enhancing investor incentive with the potential for share acquisition at a set price.
For further insights into TSE:PHRX stock, check out TipRanks’ Stock Analysis page.